Alnylam Pharmaceuticals
ALNY
#561
Rank
C$60.98 B
Marketcap
C$459.84
Share price
-0.94%
Change (1 day)
29.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company